Envoy Medical, Inc.

Anzu Special Acquisition Corp I traded on Nasdaq under the ticker ANZU after completing its initial public offering in 2021, targeting the medical technology sector. Sponsored by Anzu Partners, a venture and growth equity firm with a medtech and deep-tech focus, the SPAC pursued a business combination with Envoy Medical, Inc., a Minnesota-based medical device company best known for its Acclaim Totally Implantable Cochlear Implant, a hearing health solution for patients with moderate to severe hearing loss. The March 2023 8-K filing pertains to that proposed de-SPAC transaction, which subsequently closed with Envoy Medical listing on Nasdaq as ENVY. Sign up for full data on SpacDesk to access complete filing histories, deal timelines, and analytics across thousands of SPAC vehicles.